Biopharma Reports Fifth Quarter of Increased Net Revenues
16 5월 2023 - 12:40AM
AllPennyStocks.com
Those afflicted with sickle cell disease face many challenges
and acute complications. This biopharma company is the leader in
treatment of the disease and just reported its fifth straight
increase...
To read the full story on AllPennyStocks.com, click
here.
Emmaus Life Sciences (NASDAQ:EMMA)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Emmaus Life Sciences (NASDAQ:EMMA)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024